Intrexon Corporation News - XON

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may...

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may...

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE...

Intrexon to Present at the Bank of America Merrill Lynch 2019 Healthcare Conference PR Newswire GERMANTOWN...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

false--12-31Q120190001356090falseLarge Accelerated FilerINTREXON CORPfalse05850002000000001600204661606154161600204661606154166945000802400052...

Intrexon Reports First Quarter 2019 Financial Results -- Quarterly GAAP revenues of $23.3 million and net loss...

MAYNARD, Mass., May 02, 2019 (GLOBE NEWSWIRE) -- AquaBounty Technologies, Inc. (NASDAQ: AQB) (“AquaBounty”...

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may...

Intrexon to Release First Quarter 2019 Financial Results on May 9th PR Newswire GERMANTOWN, Md., May 2, 2019...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washin...

Table of Contents UNITED STATES SECURITIES AND...

Intrexon and Xogenex Present at American Society of Gene and Cell Therapy Annual Meeting PR Newswire GERMANTOWN...

Precigen Opens Gene and Cell Therapy Manufacturing Facility in Germantown, Maryland -Nearly 5,000 square foot...